These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31473373)

  • 21. Acute hemodynamic effects of methylxanthine therapy in preterm neonates: Effect of variations in subgroups.
    M S; Nayak K; Lewis LES; Kamath A; Purkayastha J
    J Trop Pediatr; 2019 Jun; 65(3):264-272. PubMed ID: 30085175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies surrounding xanthine therapy.
    Millar D; Schmidt B
    Semin Neonatol; 2004 Jun; 9(3):239-44. PubMed ID: 15050217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine versus theophylline for apnea in preterm infants.
    Steer PA; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (2):CD000273. PubMed ID: 10796190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wide variation in caffeine discontinuation timing in premature infants.
    Ji D; Smith PB; Clark RH; Zimmerman KO; Laughon M; Ku L; Greenberg RG
    J Perinatol; 2020 Feb; 40(2):288-293. PubMed ID: 31758062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
    Mürner-Lavanchy IM; Doyle LW; Schmidt B; Roberts RS; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W; Anderson PJ;
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apnea in the newborn.
    Aggarwal R; Singhal A; Deorari AK; Paul VK
    Indian J Pediatr; 2001 Oct; 68(10):959-62. PubMed ID: 11758133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequelae of caffeine treatment in preterm infants with apnea.
    Gunn TR; Metrakos K; Riley P; Willis D; Aranda JV
    J Pediatr; 1979 Jan; 94(1):106-9. PubMed ID: 363996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High versus standard dose caffeine for apnoea: a systematic review.
    Vliegenthart R; Miedema M; Hutten GJ; van Kaam AH; Onland W
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F523-F529. PubMed ID: 29437799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
    Ekhaguere OA; Ayede AI; Ezeaka CV
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101182. PubMed ID: 33272903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
    Marcus CL; Meltzer LJ; Roberts RS; Traylor J; Dix J; D'ilario J; Asztalos E; Opie G; Doyle LW; Biggs SN; Nixon GM; Narang I; Bhattacharjee R; Davey M; Horne RS; Cheshire M; Gibbons J; Costantini L; Bradford R; Schmidt B;
    Am J Respir Crit Care Med; 2014 Oct; 190(7):791-9. PubMed ID: 25171195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hemodynamic effects of caffeine administration in premature infants.
    Soloveychik V; Bin-Nun A; Ionchev A; Sriram S; Meadow W
    J Perinatol; 2009 Mar; 29(3):205-8. PubMed ID: 19052555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported Quality of Life at Middle School Age in Survivors of Very Preterm Birth: Results From the Caffeine for Apnea of Prematurity Trial.
    Schmidt B; Anderson PJ; Asztalos EV; Doyle LW; Grunau RE; Moddemann D; Roberts RS
    JAMA Pediatr; 2019 May; 173(5):487-489. PubMed ID: 30830144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
    Dobson NR; Hunt CE
    Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodevelopmental Outcomes in Very Low Birth Weight Infants Using Aminophylline for the Treatment of Apnea.
    Tey SL; Lee WT; Lee PL; Lu CC; Chen HL
    Pediatr Neonatol; 2016 Feb; 57(1):41-6. PubMed ID: 26141482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Winckworth LC; Powell E
    Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of theophylline use in Wolff-Parkinson-White syndrome.
    Agwunobi J; Abedin M; Young M; Beeram M; Sinkford S
    J Natl Med Assoc; 1996 Jul; 88(7):450-2. PubMed ID: 8764528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.